RGC (Regencell Bioscience Holdings) Other Current Liabilities: $0.00 Mil (As of Dec. 2025)


RGC Regencell Bioscience Holdings Ltd RGC
34 GF Score
Price $6.37
! 2 Warning Signs
View Full Analysis

What is Regencell Bioscience Holdings Other Current Liabilities?

Regencell Bioscience Holdings RGC -20.28% 34 Other Current Liabilities is $0.00 Mil as of Dec. 2025. GuruFocus rates RGC with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Regencell Bioscience Holdings's other current liabilities for the quarter that ended in Dec. 2025 was $0.00 Mil.

Regencell Bioscience Holdings's quarterly other current liabilities increased from Dec. 2024 ($0.00 Mil) to Jun. 2025 ($0.00 Mil) but then declined from Jun. 2025 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).

Regencell Bioscience Holdings's annual other current liabilities stayed the same from Jun. 2023 ($0.00 Mil) to Jun. 2024 ($0.00 Mil) but then increased from Jun. 2024 ($0.00 Mil) to Jun. 2025 ($0.00 Mil).

Regencell Bioscience Holdings Other Current Liabilities Related Terms

Regencell Bioscience Holdings Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Regencell Bioscience Holdings's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings Other Current Liabilities Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
RGC
34GF Score
Regencell Bioscience Holdings Ltd RGC
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regencell Bioscience Holdings Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.00 Mil mean?
Regencell Bioscience Holdings (RGC) has a Other Current Liabilities of $0.00 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Regencell Bioscience Holdings.
Is Regencell Bioscience Holdings' Other Current Liabilities too high?
Regencell Bioscience Holdings' current Other Current Liabilities is $0.00 Mil. Overall, Regencell Bioscience Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Regencell Bioscience Holdings' Other Current Liabilities compare to SUPN and BCRX?
Regencell Bioscience Holdings' Other Current Liabilities of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Regencell Bioscience Holdings. Regencell Bioscience Holdings's current Other Current Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regencell Bioscience Holdings stock overvalued right now?
Regencell Bioscience Holdings (RGC) has a current Other Current Liabilities of $0.00 Mil. The current Other Current Liabilities is $0.00 Mil. Regencell Bioscience Holdings' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Regencell Bioscience Holdings (RGC), the current Other Current Liabilities is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regencell Bioscience Holdings Business Description

Address 29 Leighton Road, 9th Floor, Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
34GF Score

Get the complete analysis for RGC

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37
Price